Ferrer Internacional, S.A.

Ukraine

All drugs from this manufacturer

  • ANGINOVAG

    The drug is used for the local treatment of infectious and inflammatory diseases of the oral cavity and upper respiratory tract, such as tonsillitis, pharyngitis, laryngitis, stomatitis, and glossitis.

    Dosage form: spray, oral cavity

    Active substance Dosage
    decamethonium chloride 1 mg
    tyrothricin 4 mg
    enoxolone 0.6 mg
    hydrocortisone acetate 0.6 mg
    lidocaine hydrochloride 1 mg

    ATC: R02AA20

  • The drug is used in stroke (in the acute phase and for treating consequences), in traumatic brain injuries and their neurological manifestations, as well as in memory impairment, behavioral issues, and cognitive disorders caused by vascular or degenerative brain diseases.

    Dosage form: solution for injection

    Active substance Dosage
    citicoline 500 mg/4 ml

    ATC: N06BX06

  • The drug is used in stroke (in the acute phase and for treating consequences), in traumatic brain injuries, as well as in cognitive and behavioral disorders caused by chronic vascular or degenerative brain disorders.

    Dosage form: solution, oral

    Active substance Dosage
    citicoline 100 mg/ml

    ATC: N06BX06

  • The drug is used in stroke (in the acute phase and for the treatment of its consequences), in traumatic brain injuries and their neurological consequences, as well as in behavioral disturbances and cognitive disorders caused by chronic vascular or degenerative brain diseases.

    Dosage form: solution for injection

    Active substance Dosage
    citicoline 1000 mg/4 ml

    ATC: N06BX06

  • The drug is used in the event of a stroke (in the acute phase and for the treatment of its consequences), in cases of traumatic brain injury, as well as for cognitive and behavioral impairments caused by chronic vascular or degenerative brain disorders.

    Dosage form: tablets, film-coated

    Active substance Dosage
    citicoline 500 mg

    ATC: N06BX06

  • The drug is used to treat essential arterial hypertension in patients who require combination therapy.

    Dosage form: tablets

    Active substance Dosage
    enalapril 10 mg
    nitrendipine 20 mg

    ATC: C09BB06

  • In adults, the drug is prescribed as an adjunct therapy for functional asthenia accompanied by emotional instability, impaired memory and concentration, depressive states, and low adaptability.

    Dosage form: tablets, film-coated

    Active substance Dosage
    magnesium glutamate hydrobromide 75 mg
    gamma-aminobutyric acid 75 mg
    gamma-amino-beta-oxybutyric acid 37 mg
    pyridoxine hydrochloride 37 mg

    ATC: N06BX

  • The drug is used to treat neuropathies of musculoskeletal origin (e.g., sciatica, radiculitis), metabolic origin (alcoholic or diabetic polyneuropathy), and infectious origin (herpes zoster). It is also used for facial and trigeminal neuralgia, intercostal neuralgia, and lumbago.

    Dosage form: capsules, hard

    Active substance Dosage
    cytidine 5' diphosphate disodium salt 5.0 mg
    uridine-5'-trisodium triphosphate uridine-5'-disodium diphosphate uridine-5'-disodium monophosphate 3.0 mg

    ATC: N07XX

  • The drug is used to treat neuropathies of bone and joint origin (e.g., sciatica, radiculitis), metabolic origin (alcoholic or diabetic polyneuropathy), and infectious origin (herpes zoster). It is also used for facial and trigeminal neuralgia, intercostal neuralgia, and lumbago.

    Dosage form: capsules

    Active substance Dosage
    cytidine 5 monophosphate disodium salt 5 mg
    mixture of uridine-5-triphosphate trisodium salt, uridine-5-diphosphate disodium salt and uridine-5-monophosphate disodium salt 3 mg

    ATC: N07XX

  • The drug is used to treat neuropathies of bone and joint origin (e.g., sciatica, radiculitis), metabolic origin (alcoholic, diabetic polyneuropathy), and infectious origin (herpes zoster). It is also applied for facial and trigeminal neuralgia, intercostal neuralgia, and lumbago.

    Dosage form: lyophilisate for solution for injection

    Active substance Dosage
    cytidine 5 monophosphate disodium salt 10 mg
    mixture of uridine-5-triphosphate trisodium salt, uridine-5-diphosphate disodium salt and uridine-5-monophosphate disodium salt 6 mg

    ATC: N07XX

  • The drug is used in the event of a stroke (in the acute phase and for the treatment of its consequences), in cases of traumatic brain injury, as well as for cognitive impairment and behavioral changes caused by vascular or degenerative brain disorders.

    Dosage form: solution for injection

    Active substance Dosage
    citicoline 500 mg/4 ml

    ATC: N06BX06

  • The drug is used in stroke (in the acute phase and for the treatment of consequences), in traumatic brain injuries, as well as for memory impairment, behavioral issues, and cognitive disorders caused by vascular or degenerative brain diseases.

    Dosage form: solution for injection

    Active substance Dosage
    citicoline 1000 mg/4 ml

    ATC: N06BX06

  • The drug is used in the case of stroke (in the acute phase and for treating consequences), in cases of traumatic brain injury, as well as for cognitive impairment and behavioral disorders caused by vascular or degenerative brain diseases.

    Dosage form: solution, oral

    Active substance Dosage
    citicoline 100 mg/ml

    ATC: N06BX06

  • The drug is used in the event of a stroke (in the acute phase, as well as for the treatment of consequences and complications), in cases of traumatic brain injury and its neurological consequences, as well as for memory impairment, behavioral issues, and cognitive disorders caused by vascular or degenerative brain changes.

    Dosage form: tablets, film-coated

    Active substance Dosage
    citicoline 500 mg

    ATC: N06BX06

  • The drug is used for the secondary prevention of cardiovascular complications in adult patients. It is prescribed as replacement therapy if the patient's condition is already stably controlled with other medications at equivalent doses.

    Dosage form: capsules, hard

    Active substance Dosage
    acetylsalicylic acid 100 mg
    atorvastatin 20 mg
    ramipril 10 mg

    ATC: C10BX06

  • It is used for the secondary prevention of cardiovascular complications in adult patients.

    Dosage form: capsules, hard

    Active substance Dosage
    acetylsalicylic acid 100 mg
    atorvastatin 20 mg
    ramipril 5 mg

    ATC: C10BX06

  • It is used for the secondary prevention of cardiovascular complications in adult patients whose condition is adequately controlled with other medications at appropriate doses.

    Dosage form: capsules, hard

    Active substance Dosage
    acetylsalicylic acid 100 mg
    atorvastatin 20 mg
    ramipril 2.5 mg

    ATC: C10BX06

  • It is used for the secondary prevention of cardiovascular complications in adults who have failed to achieve adequate control using individual drugs.

    Dosage form: capsules, hard

    Active substance Dosage
    acetylsalicylic acid 100 mg
    atorvastatin 40 mg
    ramipril 2.5 mg

    ATC: C10BX06

  • The drug is used for the secondary prevention of cardiovascular complications in adults, provided that their parameters (blood pressure, cholesterol levels, and blood clotting status) are properly controlled with other medications.

    Dosage form: capsules, hard

    Active substance Dosage
    acetylsalicylic acid 100 mg
    atorvastatin 40 mg
    ramipril 5 mg

    ATC: C10BX06

  • The drug is used for the secondary prevention of cardiovascular complications in adults who have achieved adequate control of risk factors (blood pressure, cholesterol levels, and blood clotting status) using other medications.

    Dosage form: capsules, hard

    Active substance Dosage
    acetylsalicylic acid 100 mg
    atorvastatin 40 mg
    ramipril 10 mg

    ATC: C10BX06